MOV Movado Group delivers narrow Q1 2026 EPS beat shares fall 226 percent on muted investor reaction Generative AI Industry IP Enforcement and CrossBorder Competitive Developments RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss